|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/68 | (2017.01) |
| A61K 47/6871 | (2017.08) | ||
| A61K 31/351 | (2006.01) | ||
| A61K 47/6803 | (2017.08) | ||
| C07D 309/10 | (2006.01) | ||
| C07D 405/14 | (2013.01) |
| (11) | Number of the document | 4025253 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20764406.3 |
| Date of filing the European patent application | 2020-09-04 | |
| (97) | Date of publication of the European application | 2022-07-13 |
| (45) | Date of publication and mention of the grant of the patent | 2024-03-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2020/074695 |
| Date | 2020-09-04 |
| (87) | Number | WO 2021/043951 |
| Date | 2021-03-11 |
| (30) | Number | Date | Country code |
| 19382765 | 2019-09-05 | EP |
| (72) |
LATORRE LOZANO, Alfonso , ES
GUTIÉRREZ LORIENTE, Agustín , ES
CUEVAS MARCHANTE, Maria Del Carmen , ES
|
| (73) |
Pharma Mar, S.A. ,
Polígono Industrial La Mina
Avda. de los Reyes, 1
Colmenar Viejo, 28770 Madrid,
ES
|
| (54) | DRUG ANTIBODY CONJUGATES |
| DRUG ANTIBODY CONJUGATES |